Trial Planning
Regulatory Agency (e.g. FDA, EMA, etc) doesn't concur with your protocol or development plan
Solutions
No sponsor launches its clinical development program with the intention of adding or switching partners along the way. Clearly, it is much more efficient and cost-effective to have the same project team throughout. However, sometimes the progress on a program gets stuck or is going in the wrong direction. When that happens, we can help.
At Veristat we have a proven track record of getting clinical development programs back on track, we know the stakes are high and you can’t afford to slow down. Let us help you move forward.
Clinical programs get stuck all the time, and many times, there is no one to blame. Sometimes the best intentions and decisions do not work out as planned. A few examples of common clinical trial challenges include:
These are the steps to help you determine if your program needs a rescue:
At Veristat, we understand that getting stuck will not keep your program accelerating forward. That is why we have a team of scientific-minded subject matter experts to get your programs unstuck.
Here is the plan of how we help you:
Regulatory Agency (e.g. FDA, EMA, etc) doesn't concur with your protocol or development plan
Patient recruitment or site activation falls behind
Quality issues or missed deadline with clinical trial data, study documentation, or deliverables.
A Regulatory Agency performs an audit and you must fix the audit findings or issues a Clinical Hold or Refusal to File